152 related articles for article (PubMed ID: 18639524)
1. Podocalyxin expression in malignant astrocytic tumors.
Hayatsu N; Kaneko MK; Mishima K; Nishikawa R; Matsutani M; Price JE; Kato Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):394-8. PubMed ID: 18639524
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of highly sulfated keratan sulfate synthesized in malignant astrocytic tumors.
Kato Y; Hayatsu N; Kaneko MK; Ogasawara S; Hamano T; Takahashi S; Nishikawa R; Matsutani M; Mishima K; Narimatsu H
Biochem Biophys Res Commun; 2008 May; 369(4):1041-6. PubMed ID: 18329383
[TBL] [Abstract][Full Text] [Related]
4. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
5. Expression of osteopontin in human glioma. Its correlation with the malignancy.
Saitoh Y; Kuratsu J; Takeshima H; Yamamoto S; Ushio Y
Lab Invest; 1995 Jan; 72(1):55-63. PubMed ID: 7837791
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors.
Dickinson PJ; Sturges BK; Higgins RJ; Roberts BN; Leutenegger CM; Bollen AW; LeCouteur RA
Vet Pathol; 2008 Mar; 45(2):131-9. PubMed ID: 18424825
[TBL] [Abstract][Full Text] [Related]
7. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma.
Mishima K; Kato Y; Kaneko MK; Nakazawa Y; Kunita A; Fujita N; Tsuruo T; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 Jun; 111(6):563-8. PubMed ID: 16718353
[TBL] [Abstract][Full Text] [Related]
9. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
[TBL] [Abstract][Full Text] [Related]
10. Podocalyxin: a marker of blasts in acute leukemia.
Kelley TW; Huntsman D; McNagny KM; Roskelley CD; Hsi ED
Am J Clin Pathol; 2005 Jul; 124(1):134-42. PubMed ID: 15923169
[TBL] [Abstract][Full Text] [Related]
11. Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors.
Nakagawa T; Kabuto M; Kubota T; Kodera T; Sato K
Anticancer Res; 1999; 19(4B):2963-8. PubMed ID: 10652580
[TBL] [Abstract][Full Text] [Related]
12. Podocalyxin is expressed in normal and leukemic monocytes.
Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
[TBL] [Abstract][Full Text] [Related]
13. [Endothelin-1 expression and quantitative analysis in astrocytomas].
Li JM; Wu XL; Zhu QJ; Wang QJ
Ai Zheng; 2002 Oct; 21(10):1109-11. PubMed ID: 12508654
[TBL] [Abstract][Full Text] [Related]
14. Keratin intermediate filament expression in astrocytic neoplasms: analysis by immunocytochemistry, western blot, and northern hybridization.
Cosgrove MM; Rich KA; Kunin SA; Sherrod AE; Martin SE
Mod Pathol; 1993 May; 6(3):342-7. PubMed ID: 7688463
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
[TBL] [Abstract][Full Text] [Related]
16. Nuclear mRNA retention and aberrant doppel protein expression in human astrocytic tumor cells.
Comincini S; Chiarelli LR; Zelini P; Del Vecchio I; Azzalin A; Arias A; Ferrara V; Rognoni P; Dipoto A; Nano R; Valentini G; Ferretti L
Oncol Rep; 2006 Dec; 16(6):1325-32. PubMed ID: 17089057
[TBL] [Abstract][Full Text] [Related]
17. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas.
Reifenberger G; Kaulich K; Wiestler OD; Blümcke I
Acta Neuropathol; 2003 Apr; 105(4):358-64. PubMed ID: 12624789
[TBL] [Abstract][Full Text] [Related]
18. Expression of Kir 4.1 in human astrocytic tumors: correlation with pathologic grade.
Tan G; Sun SQ; Yuan DL
Biochem Biophys Res Commun; 2008 Mar; 367(4):743-7. PubMed ID: 18191638
[TBL] [Abstract][Full Text] [Related]
19. The human cancer and stem cell marker podocalyxin interacts with the glucose-3-transporter in malignant pluripotent stem cells.
Schopperle WM; Lee JM; Dewolf WC
Biochem Biophys Res Commun; 2010 Jul; 398(3):372-6. PubMed ID: 20599725
[TBL] [Abstract][Full Text] [Related]
20. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
Gunal A; Onguru O; Safali M; Beyzadeoglu M
Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
